Ownership history in Redmile Group, LLC · 23 quarters on record
This page tracks every 13F SEC filing in which Redmile Group, LLC reported a position in PLIANT THERAPEUTICS INC (PLRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 1,616,228 | +24,533 | +1.5% | 0.15% | $2.0M | $1.22 |
| 2025 Q3 | REDUCED | 1,591,695 | -40,882 | -2.5% | 0.23% | $2.4M | $1.48 |
| 2025 Q2 | REDUCED | 1,632,577 | -420,982 | -20.5% | 0.20% | $1.9M | $1.16 |
| 2025 Q1 | REDUCED | 2,053,559 | -841,919 | -29.1% | 0.26% | $2.8M | $1.35 |
| 2024 Q4 | REDUCED | 2,895,478 | -302,013 | -9.4% | 2.66% | $38.1M | $13.17 |
| 2024 Q3 | REDUCED | 3,197,491 | -12,100 | -0.4% | 2.11% | $35.8M | $11.21 |
| 2024 Q2 | ADDED | 3,209,591 | +112,371 | +3.6% | 2.09% | $34.5M | $10.75 |
| 2024 Q1 | ADDED | 3,097,220 | +400,572 | +14.9% | 1.69% | $46.1M | $14.90 |
| 2023 Q4 | ADDED | 2,696,648 | +18,549 | +0.7% | 1.75% | $48.8M | $18.11 |
| 2023 Q3 | UNCHANGED | 2,678,099 | — | 0% | 2.21% | $46.4M | $17.34 |
As of 2025 Q4 — sorted by position size